Company intelligence / Profile preview

GC Research

Ownership: Private
Employees: ~1766
Development stage: Other

Overview

GC Biopharma develops and markets plasma derivatives such as albumin and immunoglobulin; vaccines for infectious diseases; prescription drugs across multiple therapeutic areas; OTC products; with ongoing R&D in cancer, tuberculosis, hunter syndrome. Recent partnerships include bispecific ADCs and mRNA-LNP therapeutics.[1][7]

Therapeutic areas: OncologyPulmonologyRare DiseasesImmunologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Plasma protein therapeutics (Biologic)Vaccines (Vaccine)Small molecule drugs (Small molecule)mRNA-based drugs (mRNA-based drugs)Bispecific antibody-drug conjugate (Antibody-drug conjugate)
Industry: Biotech

Partnerships

Chong Kun Dang PharmaceuticalDong-A ST Co.Kanaph Therapeutics

Beyond the preview

Go deeper on GC Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GC Research.

Explore the full profile